Avanir Pharmaceuticals Inc (AVNR) 16.96 $AVNR
Football Hall-of-Famer Barry Sanders Tackles Pseudobulbar Affect; A Little-known But Widespread Condition Caused by Brain Injury
PR Newswire - Wed Jan 21, 6:30AM CST
New research shows 99 percent of former professional football players surveyed by the Gridiron Greats Assistance Fund, Inc., have suffered a head injury, repeated concussions, or a blow to the head sometime during their football career. More concerning is that a third of these players admit to experiencing symptoms consistent with a little-known neurological condition caused by brain injury called Pseudobulbar Affect (PBA); and most were unaware that PBA symptoms may result from head injury. To help educate the community, legendary football Hall-of-Famer, Barry Sanders, has teamed up with Gridiron Greats and Avanir Pharmaceuticals, Inc. to launch Tackle PBA, a new educational campaign to increase awareness of PBA as a potential consequence of brain injury.
AVNR: 16.96 (unch)
Broadcom's Good Call: Exiting Cellular Chip Business
at Investor's Business Daily - Fri Jan 16, 1:04PM CST
Eric Brandt's early grounding in both engineering and business has served him well. He earned a B.S. degree in chemical engineering, followed by a Harvard MBA. Brandt, 52, is executive vice president and chief financial officer of Broadcom (BRCM), an...
AVNR: 16.96 (unch), BRCM: 45.69 (+0.23)
The Surprising Thing Most of 2014's Top 10 Stocks Have in Common
Keith Speights, The Motley Fool - Motley Fool - Sun Jan 11, 9:03AM CST
Are you good at spotting patterns? Most of us are. We even spot patterns when they're really not there -- like seeing faces in clouds. The list below of 2014's top 10 stocks with a market cap above $300 million, however, reveals a very real pattern...
AVNR: 16.96 (unch), NPSP: 45.88 (+0.03), AGIO: 118.55 (+0.11), CELG: 115.88 (+0.16), EXEL: 2.48 (+0.20)
Why Avanir Pharmaceuticals Inc. Stock Leaped 14% in December
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 06, 12:32PM CST
What: Shares of Avanir Pharmaceuticals , a biopharmaceutical company focused on developing therapies to treat central nervous system disorders, leaped 14% higher in December, according to data from S&P Capital IQ , after agreeing to be...
AVNR: 16.96 (unch)
Avanir reports 4Q loss
Automated Insights - Mon Jan 05, 1:46PM CST
ALISO VIEJO, Calif. (AP) _ Avanir Pharmaceuticals Inc. (AVNR) on Wednesday said its loss narrowed to $14.1 million in its fiscal fourth quarter.
AVNR: 16.96 (unch)
Merger Arbitrage Mondays - January 5, 2015
Asif Suria - at Seeking Alpha - Mon Jan 05, 5:34AM CST
Merger activity decreased last week with two new mergers announced and three deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: ...
NWBI: 11.91 (+0.08), TLM: 7.63 (-0.03), LO: 67.30 (-0.80), MTB: 123.90 (+0.52), MFI: 10.43 (+0.23), CNL: 53.80 (+0.10), SMPL: 17.70 (+0.20), WMGI: 25.68 (+0.17), ROC: 79.20 (+0.33), CFN: 59.81 (+0.01), HTH: 19.42 (+0.13), AUXL: 36.47 (-0.06), VSCI: 0.47 (unch), CBIN: 27.23 (+0.08), UPI: 1.27 (unch), CMSB: 13.19 (+0.13), CODE: 35.99 (+0.03), ESYS: 17.46 (+0.01), SIBC: 21.10 (+0.22), CHYR: 2.81 (+0.01), ATLS: 30.17 (+0.27), RNR: 103.80 (-0.64), COV: 106.71 (-1.36), HAL: 44.19 (+1.42), FDO: 77.86 (+0.31), EDS: 1.55 (+0.01), HCBK: 9.92 (+0.03), HBNK: 21.40 (+0.25), ESBF: 17.77 (+0.05), POM: 27.06 (-0.04), AMRE: 26.51 (unch), APAGF: 14.15 (-0.10), RNA: 18.65 (unch), XWES: 5.46 (-0.03), LNBB: 17.74 (-0.01), TRLA: 46.89 (+0.74), GRT: 14.06 (+0.10), PETM: 82.70 (+0.03), GFIG: 6.03 (-0.03), PTRY: 36.72 (+0.05), CIMT: 8.83 (+0.03), COBK: 13.41 (unch), ACT: 285.37 (+3.71), SWY: 35.10 (-0.04), ASYS: 9.87 (+0.30), NBCB: 35.20 (+0.28), MIG: 8.35 (unch), CVD: 107.08 (+0.05), VIAS: 17.37 (-0.02), BIRT: 6.60 (+0.01), AGN: 229.49 (+1.87), CACQ: 7.72 (+0.12), T: 34.66 (+0.05), IRF: 39.98 (-0.01), OILT: 44.69 (+0.29), APL: 27.30 (+0.85), CQB: 14.49 (unch), VOLC: 17.98 (+0.03), DTV: 87.51 (-0.32), SWS: 6.91 (-0.01), VYFC: 19.72 (+0.12), BNCN: 16.66 (-0.04), FRNK: 21.71 (+0.53), HVB: 26.29 (-0.36), TEG: 75.56 (-1.61), TWC: 149.74 (+2.21), DWSN: 6.89 (-0.42), GTIV: 19.19 (-0.23), SUSQ: 13.48 (+0.01), TRW: 103.60 (-0.06), BHI: 64.31 (+1.93), PTP: 76.57 (-0.13), HBOS: 24.84 (+0.14), NBTF: 29.50 (+0.20), FFKY: 3.90 (-0.20), DRC: 81.21 (+0.31), AVIV: 36.45 (-0.08), BKYF: 47.75 (-0.30), HE: 33.14 (-0.22), BTUI: 2.62 (-0.04), NGLS: 45.82 (+1.66), RNST: 27.87 (+0.28), HCT: 13.11 (+0.09), PL: 69.95 (-0.01), AVNR: 16.96 (unch), CBST: 101.94 (+0.14), RVBD: 20.85 (-0.03), SAPE: 24.98 (-0.02), PRLS: 6.96 (-0.02), PENX: 18.87 (-0.01), IGT: 17.20 (-0.04), CMCSA: 59.47 (+1.09)
The Market's Top 10 Stocks of 2014
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jan 03, 8:00AM CST
For six years now, investors have looked with skepticism at the rise in the stock market. And for a sixth straight year, the markets defied those who were waiting for a major downturn to invest, with the S&P 500 climbing about 14% including...
BLUE: 90.70 (+0.93), TTPH: 35.18 (-0.73), AVNR: 16.96 (unch), SWKS: 81.85 (-0.57), CMRX: 40.16 (+0.08), ACHN: 10.89 (-0.20), HA: 18.72 (-0.31), RCPT: 115.83 (-0.66), PTCT: 53.37 (-0.74), AGIO: 118.55 (+0.11)
Avanir's Drug-Device Combo Experiencing Minor FDA Headaches
Beacon VP Investments - at Seeking Alpha - Mon Dec 22, 1:41PM CST
AVNR: 16.96 (unch)
Market Maker Surveillance Report. JCP, T, LAMR, ODP, AVNR, BGNN, Bullishly Biased Price Friction For Monday, December 15th 2014
M2 - Tue Dec 16, 2:52AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4769 companies with "abnormal" market making, 1652 companies with positive Friction Factors and 5544 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. J C Penney Company Inc (NYSE:JCP), AT&T Inc (NYSE:T), Lamar Advertising Co (NASDAQ:LAMR), Office Depot Inc (NYSE:ODP), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), B Green Innovations Inc (OTC:BGNN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
T: 34.66 (+0.05), AVNR: 16.96 (unch), JCP: 8.05 (+0.14), LAMR: 57.55 (+0.16), ODP: 9.59 (-0.02)
3 Traits of the Best Healthcare Stocks in 2014
Sean Williams, The Motley Fool - Motley Fool - Mon Dec 15, 6:20AM CST
Source: MercK & Co., Just when it looked as though the stock market couldn't possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad...
AVNR: 16.96 (unch), RNA: 18.65 (unch), ACHN: 10.89 (-0.20), EXAS: 25.56 (-0.54), AGIO: 118.55 (+0.11)
Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announces Positive Keytruda Study Results - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Dec 12, 1:12PM CST
The Dow had a particularly disappointing week, following a slump in oil prices and disappointing overseas economic data.
CY: 14.76 (+0.01), AVNR: 16.96 (unch), GE: 25.15 (+0.26), IBM: 160.40 (+1.88), MRK: 58.81 (-0.07), INTC: 34.36 (+0.23), BA: 149.73 (+1.64), CVX: 112.78 (+1.92), CODE: 35.99 (+0.03), STO: 19.50 (+0.93)
Morgan & Morgan Announces That Class Action Lawsuits Have Been Filed in Connection With the Sale of Avanir Pharmaceuticals, Inc. -- AVNR
GlobeNewswire - Thu Dec 11, 9:12AM CST
Morgan & Morgan announces that class action lawsuits have been filed in the Delaware Court of Chancery on behalf of public stockholders of Avanir Pharmaceuticals, Inc. ("Avanir" or the "Company"
(Nasdaq:AVNR) challenging the proposed acquisition by Otsuka Pharmaceutical Co., Ltd. ("Otsuka" .
AVNR: 16.96 (unch)
Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA)
PR Newswire - Tue Dec 09, 7:30AM CST
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the initiation of production of The PBA Film Project (working title), the first-ever documentary to provide an intimate look at real people living with a little-known neurologic condition called PseudoBulbar Affect (PBA). The award-winning filmmaker team of The PBA Film Project includes co-directors Doug Blush and Lisa Klein (Of Two Minds) and producer Julian Cautherley (The Crash Reel).
AVNR: 16.96 (unch)
Merger Arbitrage Mondays - December 8, 2014
Asif Suria - Seeking Alpha - Mon Dec 08, 9:36AM CST
There was no change in merger activity last week with three new mergers announced and four deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal...
CY: 14.76 (+0.01), HE: 33.14 (-0.22), EMN: 75.67 (+0.56), ANY: 3.52 (+0.05), FRF: 9.97 (+0.04), TIPT: 7.49 (+0.01), TAM: 26.00 (+0.01), CNQR: 128.78 (-0.02), NEE: 103.62 (-1.72), AVNR: 16.96 (unch), SAP: 69.09 (unch), OVRL: 3.48 (-0.30), CODE: 35.99 (+0.03)
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Mon Dec 08, 8:11AM CST
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
MOLG: 2.46 (+0.03), AVNR: 16.96 (unch), HE: 33.14 (-0.22), ADHD: 6.92 (+0.73), NYMX: 0.36 (-0.02), SDRL: 12.32 (-0.70), SNY: 49.42 (+0.82), AMRI: 16.94 (-0.28), CIE: 8.90 (+0.20)
Dow 30 Stock Roundup: Chevron Starts Production at Jack/St. Malo Project, UnitedHealth Provides Guidance - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Dec 05, 3:15PM CST
The Dow had a mixed week, swinging between gains and losses.
CY: 14.76 (+0.01), AVNR: 16.96 (unch), RYAAY: 61.46 (-2.33), ADP: 88.75 (+1.00), IBM: 160.40 (+1.88), UNH: 109.44 (-0.40), TXN: 57.97 (+0.53), GOOGL: 551.16 (+5.15), INTC: 34.36 (+0.23), BA: 149.73 (+1.64), CVX: 112.78 (+1.92), CODE: 35.99 (+0.03)
Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call
PR Newswire - Fri Dec 05, 3:01PM CST
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that, as a result of the entry by Avanir Pharmaceuticals into an agreement and plan of merger with Otsuka Pharmaceutical Co., Ltd., and Bigarade Corporation, a wholly owned subsidiary of Otsuka Pharmaceutical, on December 1, 2014, Avanir Pharmaceuticals is cancelling its previously scheduled Fiscal 2014 Fourth Quarter Financial Results and Conference Call.
AVNR: 16.96 (unch)
Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc.
PR Newswire - Thu Dec 04, 12:21PM CST
Avanir Pharmaceuticals, Inc.
CARB: 14.96 (+0.07), AVNR: 16.96 (unch), RLD: 12.65 (+0.16), NYMX: 0.36 (-0.02), CASY: 88.93 (-1.10), PBYI: 205.26 (+2.75), CODE: 35.99 (+0.03)
AVNR INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Avanir Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Otsuka Pharmaceutical Co., Ltd. -- AVNR
PR Newswire - Thu Dec 04, 10:57AM CST
Levi & Korsinsky is investigating the Board of Directors of Avanir Pharmaceuticals, Inc. ("Avanir" or "the Company" (NasdaqGS: AVNR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Otsuka Pharmaceutical Co., Ltd.
AVNR: 16.96 (unch)
Football Hall-of-Famer Barry Sanders Tackles Pseudobulbar Affect; A Little-known But Widespread Condition Caused by Brain Injury
PR Newswire - Wed Jan 21, 6:30AM CST
New research shows 99 percent of former professional football players surveyed by the Gridiron Greats Assistance Fund, Inc., have suffered a head injury, repeated concussions, or a blow to the head sometime during their football career. More concerning is that a third of these players admit to experiencing symptoms consistent with a little-known neurological condition caused by brain injury called Pseudobulbar Affect (PBA); and most were unaware that PBA symptoms may result from head injury. To help educate the community, legendary football Hall-of-Famer, Barry Sanders, has teamed up with Gridiron Greats and Avanir Pharmaceuticals, Inc. to launch Tackle PBA, a new educational campaign to increase awareness of PBA as a potential consequence of brain injury.
AVNR: 16.96 (unch)
Broadcom's Good Call: Exiting Cellular Chip Business
at Investor's Business Daily - Fri Jan 16, 1:04PM CST
Eric Brandt's early grounding in both engineering and business has served him well. He earned a B.S. degree in chemical engineering, followed by a Harvard MBA. Brandt, 52, is executive vice president and chief financial officer of Broadcom (BRCM), an...
AVNR: 16.96 (unch), BRCM: 45.69 (+0.23)
The Surprising Thing Most of 2014's Top 10 Stocks Have in Common
Keith Speights, The Motley Fool - Motley Fool - Sun Jan 11, 9:03AM CST
Are you good at spotting patterns? Most of us are. We even spot patterns when they're really not there -- like seeing faces in clouds. The list below of 2014's top 10 stocks with a market cap above $300 million, however, reveals a very real pattern...
AVNR: 16.96 (unch), NPSP: 45.88 (+0.03), AGIO: 118.55 (+0.11), CELG: 115.88 (+0.16), EXEL: 2.48 (+0.20)
Why Avanir Pharmaceuticals Inc. Stock Leaped 14% in December
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 06, 12:32PM CST
What: Shares of Avanir Pharmaceuticals , a biopharmaceutical company focused on developing therapies to treat central nervous system disorders, leaped 14% higher in December, according to data from S&P Capital IQ , after agreeing to be...
AVNR: 16.96 (unch)
Avanir reports 4Q loss
Automated Insights - Mon Jan 05, 1:46PM CST
ALISO VIEJO, Calif. (AP) _ Avanir Pharmaceuticals Inc. (AVNR) on Wednesday said its loss narrowed to $14.1 million in its fiscal fourth quarter.
AVNR: 16.96 (unch)
Merger Arbitrage Mondays - January 5, 2015
Asif Suria - at Seeking Alpha - Mon Jan 05, 5:34AM CST
Merger activity decreased last week with two new mergers announced and three deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: ...
NWBI: 11.91 (+0.08), TLM: 7.63 (-0.03), LO: 67.30 (-0.80), MTB: 123.90 (+0.52), MFI: 10.43 (+0.23), CNL: 53.80 (+0.10), SMPL: 17.70 (+0.20), WMGI: 25.68 (+0.17), ROC: 79.20 (+0.33), CFN: 59.81 (+0.01), HTH: 19.42 (+0.13), AUXL: 36.47 (-0.06), VSCI: 0.47 (unch), CBIN: 27.23 (+0.08), UPI: 1.27 (unch), CMSB: 13.19 (+0.13), CODE: 35.99 (+0.03), ESYS: 17.46 (+0.01), SIBC: 21.10 (+0.22), CHYR: 2.81 (+0.01), ATLS: 30.17 (+0.27), RNR: 103.80 (-0.64), COV: 106.71 (-1.36), HAL: 44.19 (+1.42), FDO: 77.86 (+0.31), EDS: 1.55 (+0.01), HCBK: 9.92 (+0.03), HBNK: 21.40 (+0.25), ESBF: 17.77 (+0.05), POM: 27.06 (-0.04), AMRE: 26.51 (unch), APAGF: 14.15 (-0.10), RNA: 18.65 (unch), XWES: 5.46 (-0.03), LNBB: 17.74 (-0.01), TRLA: 46.89 (+0.74), GRT: 14.06 (+0.10), PETM: 82.70 (+0.03), GFIG: 6.03 (-0.03), PTRY: 36.72 (+0.05), CIMT: 8.83 (+0.03), COBK: 13.41 (unch), ACT: 285.37 (+3.71), SWY: 35.10 (-0.04), ASYS: 9.87 (+0.30), NBCB: 35.20 (+0.28), MIG: 8.35 (unch), CVD: 107.08 (+0.05), VIAS: 17.37 (-0.02), BIRT: 6.60 (+0.01), AGN: 229.49 (+1.87), CACQ: 7.72 (+0.12), T: 34.66 (+0.05), IRF: 39.98 (-0.01), OILT: 44.69 (+0.29), APL: 27.30 (+0.85), CQB: 14.49 (unch), VOLC: 17.98 (+0.03), DTV: 87.51 (-0.32), SWS: 6.91 (-0.01), VYFC: 19.72 (+0.12), BNCN: 16.66 (-0.04), FRNK: 21.71 (+0.53), HVB: 26.29 (-0.36), TEG: 75.56 (-1.61), TWC: 149.74 (+2.21), DWSN: 6.89 (-0.42), GTIV: 19.19 (-0.23), SUSQ: 13.48 (+0.01), TRW: 103.60 (-0.06), BHI: 64.31 (+1.93), PTP: 76.57 (-0.13), HBOS: 24.84 (+0.14), NBTF: 29.50 (+0.20), FFKY: 3.90 (-0.20), DRC: 81.21 (+0.31), AVIV: 36.45 (-0.08), BKYF: 47.75 (-0.30), HE: 33.14 (-0.22), BTUI: 2.62 (-0.04), NGLS: 45.82 (+1.66), RNST: 27.87 (+0.28), HCT: 13.11 (+0.09), PL: 69.95 (-0.01), AVNR: 16.96 (unch), CBST: 101.94 (+0.14), RVBD: 20.85 (-0.03), SAPE: 24.98 (-0.02), PRLS: 6.96 (-0.02), PENX: 18.87 (-0.01), IGT: 17.20 (-0.04), CMCSA: 59.47 (+1.09)
The Market's Top 10 Stocks of 2014
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jan 03, 8:00AM CST
For six years now, investors have looked with skepticism at the rise in the stock market. And for a sixth straight year, the markets defied those who were waiting for a major downturn to invest, with the S&P 500 climbing about 14% including...
BLUE: 90.70 (+0.93), TTPH: 35.18 (-0.73), AVNR: 16.96 (unch), SWKS: 81.85 (-0.57), CMRX: 40.16 (+0.08), ACHN: 10.89 (-0.20), HA: 18.72 (-0.31), RCPT: 115.83 (-0.66), PTCT: 53.37 (-0.74), AGIO: 118.55 (+0.11)
Avanir's Drug-Device Combo Experiencing Minor FDA Headaches
Beacon VP Investments - at Seeking Alpha - Mon Dec 22, 1:41PM CST
AVNR: 16.96 (unch)
Market Maker Surveillance Report. JCP, T, LAMR, ODP, AVNR, BGNN, Bullishly Biased Price Friction For Monday, December 15th 2014
M2 - Tue Dec 16, 2:52AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4769 companies with "abnormal" market making, 1652 companies with positive Friction Factors and 5544 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. J C Penney Company Inc (NYSE:JCP), AT&T Inc (NYSE:T), Lamar Advertising Co (NASDAQ:LAMR), Office Depot Inc (NYSE:ODP), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), B Green Innovations Inc (OTC:BGNN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
T: 34.66 (+0.05), AVNR: 16.96 (unch), JCP: 8.05 (+0.14), LAMR: 57.55 (+0.16), ODP: 9.59 (-0.02)
3 Traits of the Best Healthcare Stocks in 2014
Sean Williams, The Motley Fool - Motley Fool - Mon Dec 15, 6:20AM CST
Source: MercK & Co., Just when it looked as though the stock market couldn't possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad...
AVNR: 16.96 (unch), RNA: 18.65 (unch), ACHN: 10.89 (-0.20), EXAS: 25.56 (-0.54), AGIO: 118.55 (+0.11)
Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announces Positive Keytruda Study Results - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Dec 12, 1:12PM CST
The Dow had a particularly disappointing week, following a slump in oil prices and disappointing overseas economic data.
CY: 14.76 (+0.01), AVNR: 16.96 (unch), GE: 25.15 (+0.26), IBM: 160.40 (+1.88), MRK: 58.81 (-0.07), INTC: 34.36 (+0.23), BA: 149.73 (+1.64), CVX: 112.78 (+1.92), CODE: 35.99 (+0.03), STO: 19.50 (+0.93)
Morgan & Morgan Announces That Class Action Lawsuits Have Been Filed in Connection With the Sale of Avanir Pharmaceuticals, Inc. -- AVNR
GlobeNewswire - Thu Dec 11, 9:12AM CST
Morgan & Morgan announces that class action lawsuits have been filed in the Delaware Court of Chancery on behalf of public stockholders of Avanir Pharmaceuticals, Inc. ("Avanir" or the "Company"
(Nasdaq:AVNR) challenging the proposed acquisition by Otsuka Pharmaceutical Co., Ltd. ("Otsuka" . AVNR: 16.96 (unch)
Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA)
PR Newswire - Tue Dec 09, 7:30AM CST
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the initiation of production of The PBA Film Project (working title), the first-ever documentary to provide an intimate look at real people living with a little-known neurologic condition called PseudoBulbar Affect (PBA). The award-winning filmmaker team of The PBA Film Project includes co-directors Doug Blush and Lisa Klein (Of Two Minds) and producer Julian Cautherley (The Crash Reel).
AVNR: 16.96 (unch)
Merger Arbitrage Mondays - December 8, 2014
Asif Suria - Seeking Alpha - Mon Dec 08, 9:36AM CST
There was no change in merger activity last week with three new mergers announced and four deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal...
CY: 14.76 (+0.01), HE: 33.14 (-0.22), EMN: 75.67 (+0.56), ANY: 3.52 (+0.05), FRF: 9.97 (+0.04), TIPT: 7.49 (+0.01), TAM: 26.00 (+0.01), CNQR: 128.78 (-0.02), NEE: 103.62 (-1.72), AVNR: 16.96 (unch), SAP: 69.09 (unch), OVRL: 3.48 (-0.30), CODE: 35.99 (+0.03)
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Mon Dec 08, 8:11AM CST
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
MOLG: 2.46 (+0.03), AVNR: 16.96 (unch), HE: 33.14 (-0.22), ADHD: 6.92 (+0.73), NYMX: 0.36 (-0.02), SDRL: 12.32 (-0.70), SNY: 49.42 (+0.82), AMRI: 16.94 (-0.28), CIE: 8.90 (+0.20)
Dow 30 Stock Roundup: Chevron Starts Production at Jack/St. Malo Project, UnitedHealth Provides Guidance - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Dec 05, 3:15PM CST
The Dow had a mixed week, swinging between gains and losses.
CY: 14.76 (+0.01), AVNR: 16.96 (unch), RYAAY: 61.46 (-2.33), ADP: 88.75 (+1.00), IBM: 160.40 (+1.88), UNH: 109.44 (-0.40), TXN: 57.97 (+0.53), GOOGL: 551.16 (+5.15), INTC: 34.36 (+0.23), BA: 149.73 (+1.64), CVX: 112.78 (+1.92), CODE: 35.99 (+0.03)
Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call
PR Newswire - Fri Dec 05, 3:01PM CST
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that, as a result of the entry by Avanir Pharmaceuticals into an agreement and plan of merger with Otsuka Pharmaceutical Co., Ltd., and Bigarade Corporation, a wholly owned subsidiary of Otsuka Pharmaceutical, on December 1, 2014, Avanir Pharmaceuticals is cancelling its previously scheduled Fiscal 2014 Fourth Quarter Financial Results and Conference Call.
AVNR: 16.96 (unch)
Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc.
PR Newswire - Thu Dec 04, 12:21PM CST
Avanir Pharmaceuticals, Inc.
CARB: 14.96 (+0.07), AVNR: 16.96 (unch), RLD: 12.65 (+0.16), NYMX: 0.36 (-0.02), CASY: 88.93 (-1.10), PBYI: 205.26 (+2.75), CODE: 35.99 (+0.03)
AVNR INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Avanir Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Otsuka Pharmaceutical Co., Ltd. -- AVNR
PR Newswire - Thu Dec 04, 10:57AM CST
Levi & Korsinsky is investigating the Board of Directors of Avanir Pharmaceuticals, Inc. ("Avanir" or "the Company"
(NasdaqGS: AVNR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Otsuka Pharmaceutical Co., Ltd. AVNR: 16.96 (unch)
